MICHELLAMINE A

ID: ALA295292

Max Phase: Preclinical

Molecular Formula: C46H48N2O8

Molecular Weight: 756.90

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C)cc2c(-c3c(O)cc(O)c4c3C[C@@H](C)N[C@@H]4C)cc(-c3cc(-c4c(O)cc(O)c5c4C[C@@H](C)N[C@@H]5C)c4cc(C)cc(OC)c4c3O)c(O)c12

Standard InChI:  InChI=1S/C46H48N2O8/c1-19-9-25-27(41-31-13-21(3)47-23(5)39(31)33(49)17-35(41)51)15-29(45(53)43(25)37(11-19)55-7)30-16-28(26-10-20(2)12-38(56-8)44(26)46(30)54)42-32-14-22(4)48-24(6)40(32)34(50)18-36(42)52/h9-12,15-18,21-24,47-54H,13-14H2,1-8H3/t21-,22-,23-,24-/m1/s1

Standard InChI Key:  GMLBVLXDRNJFGR-MOUTVQLLSA-N

Associated Targets(Human)

CEM-SS 2428 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MT2 2907 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

C-344 cell line 2 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

C8166 1658 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

LDV-7 cell line 2 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 70413 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Micrococcus flavus 568 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pseudomonas putida 467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phospho-N-acetylmuramoyl-pentapeptide-transferase 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 756.90Molecular Weight (Monoisotopic): 756.3411AlogP: 9.05#Rotatable Bonds: 5
Polar Surface Area: 163.90Molecular Species: BASEHBA: 10HBD: 8
#RO5 Violations: 3HBA (Lipinski): 10HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.72CX Basic pKa: 10.88CX LogP: 6.15CX LogD: 5.24
Aromatic Rings: 6Heavy Atoms: 56QED Weighted: 0.09Np Likeness Score: 1.02

References

1. Boyd MR, Hallock YF, Cardellina JH, Manfredi KP, Blunt JW, McMahon JB, Buckheit RW, Bringmann G, Schäffer M, Cragg GM..  (1994)  Anti-HIV michellamines from Ancistrocladus korupensis.,  37  (12): [PMID:8021914] [10.1021/jm00038a003]
2. Boyd MR, Hallock YF, Cardellina JH, Manfredi KP, Blunt JW, McMahon JB, Buckheit RW, Bringmann G, Schäffer M, Cragg GM..  (1994)  Anti-HIV michellamines from Ancistrocladus korupensis.,  37  (12): [PMID:8021914] [10.1021/jm00038a003]
3. Boyd MR, Hallock YF, Cardellina JH, Manfredi KP, Blunt JW, McMahon JB, Buckheit RW, Bringmann G, Schäffer M, Cragg GM..  (1994)  Anti-HIV michellamines from Ancistrocladus korupensis.,  37  (12): [PMID:8021914] [10.1021/jm00038a003]
4. Hallock YF, Manfredi KP, Dai JR, Cardellina JH, Gulakowski RJ, McMahon JB, Schäffer M, Stahl M, Gulden KP, Bringmann G, François G, Boyd MR..  (1997)  Michellamines D-F, new HIV-inhibitory dimeric naphthylisoquinoline alkaloids, and korupensamine E, a new antimalarial monomer, from Ancistrocladus korupensis.,  60  (7): [PMID:9249970] [10.1021/np9700679]
5. Yang SS, Cragg GM, Newman DJ, Bader JP..  (2001)  Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.,  64  (2): [PMID:11430019] [10.1021/np0003995]
6. Mihalyi A, Jamshidi S, Slikas J, Bugg TD..  (2014)  Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.,  22  (17): [PMID:25127465] [10.1016/j.bmc.2014.07.035]

Source